A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal 
BiomX to Host Second Quarter 2021 Financial Results Conference Call and Webcast on August 16, 2021
NESS ZIONA, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage...
Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board of Directors
REHOVOT, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based...
Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under the Symbol ‘AWKNF’ on August 12th
Toronto, Ontario--(Newsfile Corp. - August 12, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) ('Awakn'), a biotechnology company...
NextGen Healthcare Announces Date for 2021 Annual Meeting of Shareholders
ATLANTA--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, will hold its 2021 Annual Meeting...
CORRECTING and REPLACING Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Presentation time in the release dated August 2, 2021, should read 8:00 am PT on Thursday, August...
Emerald Health Therapeutics Comments on Board Resignation
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2021) - Further to its press release of August 6th, Emerald Health Therapeutics,...
Defence Therapeutics Receives DTC Eligibility
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2021) - Defence Therapeutics Inc. (CSE: DTC) ("Defence" or the "Company"), a biotechnology...
KORU Medical Systems Announces 2021 Second Quarter Financial Results
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical...
StageZero to Issue Q2 2021 Financial Results and Hold Conference Call on Tuesday, August 17
TORONTO, ON / ACCESSWIRE / August 11, 2021 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that...
Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical...
Cloud DX to Host Earnings Webcast Tuesday August 17th, 2021
WATERLOO, ON / ACCESSWIRE / August 11, 2021 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), (the 'Company') a leading North American provider of...
Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution
Highlights Clinical trial for XPERIENCE commences after receiving FDA clearance in April Randomized, controlled, double-blinded study will evaluate the effects...
Sorrento and Dyadic Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including Greater China and Japan) and...
Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021
CHERRY HILL, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug...
Creo appoints commercial leader Graeme Kenny as Chief Revenue Officer
Creo appoints commercial leader Graeme Kenny as Chief Revenue Officer Head of Croda Personal Care in North America joins Creo...
Allied Corp Adds Additional 31 Acres of Land While Scaling Production Center in Colombia
KELOWNA, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including Greater China and Japan) and...
Predictive Oncology Adjourns Special Meeting of Stockholders
MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to...
The 357 Company Launches 357 Kerbsyde Last Mile Delivery Service
357 Kerbsyde Network and Fulfillment Centers The 357 Company launches 357 Kerbsyde, a last-mile delivery service for B2B and D2C,...
Skye Bioscience to Present at the H.C. Wainwright Ophthalmology Conference
SAN DIEGO, CA, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary,...